ISG15 governs mitochondrial function in macrophages following vaccinia virus infection

PLoS Pathogens

Volumn 13, Issue 10, 2017, Pages

  Baldanta, Sara ^a   Fernández Escobar, Mercedes ^a   Acín Perez, Rebeca ^b   Albert, Manuel ^a   Camafeita, Emilio ^b   Jorge, Inmaculada ^b   Vázquez, Jesús ^b   Enríquez, José Antonio ^b   Guerra, Susana ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARGINASE 1; AUTOPHAGY RELATED PROTEIN 5; AUTOPHAGY RELATED PROTEIN 7; BETA INTERFERON; CITRATE SYNTHASE; DYNAMIN I; INTERFERON; INTERFERON STIMULATED GENE 15; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; NITRIC OXIDE; PROTEINASE K; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ARG1 PROTEIN, MOUSE; ARGINASE; CYTOKINE; G1P2 PROTEIN, MOUSE; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL METABOLISM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; INFLAMMATION; MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; MITOPHAGY; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PHENOTYPE; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VACCINIA; VACCINIA VIRUS; VIRUS IMMUNITY; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; ENZYME ACTIVATION; GENETICS; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; MITOCHONDRION; PATHOLOGY;

ANIMALS; ARGINASE; CYTOKINES; ENZYME ACTIVATION; MACROPHAGES; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; NITRIC OXIDE; OXIDATIVE PHOSPHORYLATION; UBIQUITINS; VACCINIA; VACCINIA VIRUS;

EID: 85032634740     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006651     Document Type: Article

References (89)

1. Durfee LA, Huibregtse JM, The ISG15 conjugation system. Methods Mol Biol. 2012;832:141–9. doi: 10.1007/978-1-61779-474-2_9 22350882.
2. Ketscher L, Knobeloch KP, ISG15 uncut: Dissecting enzymatic and non-enzymatic functions of USP18 in vivo. Cytokine. 2015;76(2):569–71. doi: 10.1016/j.cyto.2015.03.006 25805508.
3. Rahnefeld A, Klingel K, Schuermann A, Diny NL, Althof N, Lindner A, et al. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy. Circulation. 2014;130(18):1589–600. doi: 10.1161/CIRCULATIONAHA.114.009847 25165091.
4. Zhao C, Hsiang TY, Kuo RL, Krug RM, ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(5):2253–8. doi: 10.1073/pnas.0909144107 20133869
5. Durfee LA, Lyon N, Seo K, Huibregtse JM, The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol Cell. 2010;38(5):722–32. doi: 10.1016/j.molcel.2010.05.002 20542004.
6. Villarroya-Beltri C, Guerra S, Sanchez-Madrid F, ISGylation—a key to lock the cell gates for preventing the spread of threats. J Cell Sci. 2017. doi: 10.1242/jcs.205468 28842471.
7. Pincetic A, Kuang Z, Seo EJ, Leis J, The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J Virol. 2010;84(9):4725–36. doi: 10.1128/JVI.02478-09 20164219.
8. Tang Y, Zhong G, Zhu L, Liu X, Shan Y, Feng H, et al. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J Immunol. 2010;184(10):5777–90. Epub 2010/04/14. doi: 10.4049/jimmunol.0903588 20385878.
9. Zhao C, Hsiang TY, Kuo RL, Krug RM, ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci U S A. 2010;107(5):2253–8. doi: 10.1073/pnas.0909144107 20133869.
10. Zhao C, Sridharan H, Chen R, Baker DP, Wang S, Krug RM, Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins. Nat Commun. 2016;7:12754. doi: 10.1038/ncomms12754 27587337.
11. Okumura A, Lu G, Pitha-Rowe I, Pitha PM, Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A. 2006;103(5):1440–5. doi: 10.1073/pnas.0510518103 16434471.
12. Malakhova OA, Zhang DE, ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem. 2008;283(14):8783–7. doi: 10.1074/jbc.C800030200 18287095.
13. Lenschow DJ, Antiviral Properties of ISG15. Viruses. 2010;2(10):2154–68. doi: 10.3390/v2102154 21994614.
14. Radoshevich L, Impens F, Ribet D, Quereda JJ, Nam Tham T, Nahori MA, et al. ISG15 counteracts Listeria monocytogenes infection. Elife. 2015;4. doi: 10.7554/eLife.06848 26259872.
15. Kimmey JM, Campbell JA, Weiss LA, Monte KJ, Lenschow DJ, Stallings CL, The impact of ISGylation during Mycobacterium tuberculosis infection in mice. Microbes Infect. 2017. doi: 10.1016/j.micinf.2016.12.006 28087453.
16. Ketscher L, Hannss R, Morales DJ, Basters A, Guerra S, Goldmann T, et al. Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. Proc Natl Acad Sci U S A. 2015;112(5):1577–82. doi: 10.1073/pnas.1412881112 25605921.
17. Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D, et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Science. 2012;337(6102):1684–8. doi: 10.1126/science.1224026 22859821.
18. Zhang X, Bogunovic D, Payelle-Brogard B, Francois-Newton V, Speer SD, Yuan C, et al. Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation. Nature. 2015;517(7532):89–93. doi: 10.1038/nature13801 25307056.
19. Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, et al. ISG15 deficiency and increased viral resistance in humans but not mice. Nat Commun. 2016;7:11496. doi: 10.1038/ncomms11496 27193971.
20. Guerra S, Caceres A, Knobeloch KP, Horak I, Esteban M, Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 2008;4(7):e1000096. doi: 10.1371/journal.ppat.1000096 18604270.
21. Eduardo-Correia B, Martinez-Romero C, Garcia-Sastre A, Guerra S, ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection. J Virol. 2014;88(4):2312–8. doi: 10.1128/JVI.03293-13 24257616.
22. Yanguez E, Garcia-Culebras A, Frau A, Llompart C, Knobeloch KP, Gutierrez-Erlandsson S, et al. ISG15 regulates peritoneal macrophages functionality against viral infection. PLoS Pathog. 2013;9(10):e1003632. doi: 10.1371/journal.ppat.1003632 24137104.
23. Sainz B, Jr.Martin B, Tatari M, Heeschen C, Guerra S, ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells. Cancer Res. 2014;74(24):7309–20. doi: 10.1158/0008-5472.CAN-14-1354 25368022.
24. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20. doi: 10.1016/j.immuni.2014.06.008 25035950.
25. Biswas SK, Mantovani A, Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889–96. doi: 10.1038/ni.1937 20856220.
26. Gordon S, Taylor PR, Monocyte and macrophage heterogeneity. Nature reviews Immunology. 2005;5(12):953–64. doi: 10.1038/nri1733 16322748.
27. Sica A, Mantovani A, Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122(3):787–95. doi: 10.1172/JCI59643 22378047.
28. Benoit M, Desnues B, Mege JL, Macrophage polarization in bacterial infections. J Immunol. 2008;181(6):3733–9. 18768823.
29. Garaude J, Acin-Perez R, Martinez-Cano S, Enamorado M, Ugolini M, Nistal-Villan E, et al. Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense. Nat Immunol. 2016;17(9):1037–45. doi: 10.1038/ni.3509 27348412.
30. Mills EL, O'Neill LA, Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur J Immunol. 2016;46(1):13–21. doi: 10.1002/eji.201445427 26643360.
31. Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. Journal of immunology. 2010;185(1):605–14. doi: 10.4049/jimmunol.0901698 20498354.
32. Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, Jacobs BS, et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun. 2005;336(2):496–506. doi: 10.1016/j.bbrc.2005.08.132 16139798.
33. Zhao H, Yang J, Li K, Ding X, Lin R, Ma Y, et al. Proteomic analysis at the subcellular level for host targets against influenza A virus (H1N1). Antiviral Res. 2013;100(3):673–87. doi: 10.1016/j.antiviral.2013.10.005 24161511.
34. Sancak Y, Markhard AL, Kitami T, Kovacs-Bogdan E, Kamer KJ, Udeshi ND, et al. EMRE is an essential component of the mitochondrial calcium uniporter complex. Science. 2013;342(6164):1379–82. doi: 10.1126/science.1242993 24231807.
35. Harner M, Korner C, Walther D, Mokranjac D, Kaesmacher J, Welsch U, et al. The mitochondrial contact site complex, a determinant of mitochondrial architecture. EMBO J. 2011;30(21):4356–70. doi: 10.1038/emboj.2011.379 22009199.
36. Guarani V, McNeill EM, Paulo JA, Huttlin EL, Frohlich F, Gygi SP, et al. QIL1 is a novel mitochondrial protein required for MICOS complex stability and cristae morphology. Elife. 2015;4. doi: 10.7554/eLife.06265 25997101.
37. Kurihara Y, Kanki T, Aoki Y, Hirota Y, Saigusa T, Uchiumi T, et al. Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast. J Biol Chem. 2012;287(5):3265–72. doi: 10.1074/jbc.M111.280156 22157017.
38. Pourcelot M, Arnoult D, Mitochondrial dynamics and the innate antiviral immune response. FEBS J. 2014;281(17):3791–802. doi: 10.1111/febs.12940 25051991.
39. Cogliati S, Frezza C, Soriano ME, Varanita T, Quintana-Cabrera R, Corrado M, et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell. 2013;155(1):160–71. doi: 10.1016/j.cell.2013.08.032 24055366.
40. Mishra P, Chan DC, Metabolic regulation of mitochondrial dynamics. J Cell Biol. 2016;212(4):379–87. doi: 10.1083/jcb.201511036 26858267.
41. Nakashima H, Nguyen T, Goins WF, Chiocca EA, Interferon-stimulated gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1/p62. J Biol Chem. 2015;290(3):1485–95. doi: 10.1074/jbc.M114.593871 25429107.
42. Ivankovic D, Chau KY, Schapira AH, Gegg ME, Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin-mediated mitophagy. J Neurochem. 2016;136(2):388–402. doi: 10.1111/jnc.13412 26509433.
43. Izquierdo E, Cuevas VD, Fernandez-Arroyo S, Riera-Borrull M, Orta-Zavalza E, Joven J, et al. Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways. J Immunol. 2015;195(5):2442–51. doi: 10.4049/jimmunol.1403045 26209622.
44. Biswas SK, Mantovani A, Orchestration of metabolism by macrophages. Cell Metab. 2012;15(4):432–7. doi: 10.1016/j.cmet.2011.11.013 22482726.
45. Odegaard JI, Chawla A, The immune system as a sensor of the metabolic state. Immunity. 2013;38(4):644–54. doi: 10.1016/j.immuni.2013.04.001 23601683.
46. Galvan-Pena S, O'Neill LA, Metabolic reprograming in macrophage polarization. Front Immunol. 2014;5:420. doi: 10.3389/fimmu.2014.00420 25228902.
47. Malyshev I, Malyshev Y, Current Concept and Update of the Macrophage Plasticity Concept: Intracellular Mechanisms of Reprogramming and M3 Macrophage "Switch" Phenotype. Biomed Res Int. 2015;2015:341308. doi: 10.1155/2015/341308 26366410.
48. Vrbacky M, Krijt J, Drahota Z, Melkova Z, Inhibitory effects of Bcl-2 on mitochondrial respiration. Physiol Res. 2003;52(5):545–54. 14535829.
49. Gregorczyk KP, Szulc-Dabrowska L, Wyzewski Z, Struzik J, Niemialtowski M, Changes in the mitochondrial network during ectromelia virus infection of permissive L929 cells. Acta Biochim Pol. 2014;61(1):171–7. 24660173.
50. Anand SK, Tikoo SK, Viruses as modulators of mitochondrial functions. Adv Virol. 2013;2013:738794. doi: 10.1155/2013/738794 24260034.
51. Morales DJ, Lenschow DJ, The antiviral activities of ISG15. J Mol Biol. 2013;425(24):4995–5008. doi: 10.1016/j.jmb.2013.09.041 24095857.
52. Harty RN, Pitha PM, Okumura A, Antiviral activity of innate immune protein ISG15. J Innate Immun. 2009;1(5):397–404. doi: 10.1159/000226245 19680460.
53. Wu D, Sanin DE, Everts B, Chen Q, Qiu J, Buck MD, et al. Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function. Immunity. 2016;44(6):1325–36. doi: 10.1016/j.immuni.2016.06.006 27332732.
54. Yim HY, Yang Y, Lim JS, Lee MS, Zhang DE, Kim KI, The mitochondrial pathway and reactive oxygen species are critical contributors to interferon-alpha/beta-mediated apoptosis in Ubp43-deficient hematopoietic cells. Biochem Biophys Res Commun. 2012;423(2):436–40. 22683641.
55. Jackson WT, Viruses and the autophagy pathway. Virology. 2015;479–480:450–6. doi: 10.1016/j.virol.2015.03.042 25858140.
56. Nakahira K, Choi AM, Autophagy: a potential therapeutic target in lung diseases. Am J Physiol Lung Cell Mol Physiol. 2013;305(2):L93–107. doi: 10.1152/ajplung.00072.2013 23709618.
57. Schmeisser H, Bekisz J, Zoon KC, New function of type I IFN: induction of autophagy. J Interferon Cytokine Res. 2014;34(2):71–8. doi: 10.1089/jir.2013.0128 24428799.
58. Villarroya-Beltri C, Baixauli F, Mittelbrunn M, Fernández-Delgado I, Torralba D, Moreno-Gonzalo O, et al. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat Commun. 2016.
59. Xu D, Zhang T, Xiao J, Zhu K, Wei R, Wu Z, et al. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon. Autophagy. 2015;11(4):617–28. doi: 10.1080/15548627.2015.1023982 25906440.
60. Khan M, Syed GH, Kim SJ, Siddiqui A, Mitochondrial dynamics and viral infections: A close nexus. Biochim Biophys Acta. 2015;1853(10 Pt B):2822–33. doi: 10.1016/j.bbamcr.2014.12.040 25595529.
61. Greseth MD, Traktman P, De novo fatty acid biosynthesis contributes significantly to establishment of a bioenergetically favorable environment for vaccinia virus infection. PLoS Pathog. 2014;10(3):e1004021. doi: 10.1371/journal.ppat.1004021 24651651.
62. Lee JY, Kim DG, Kim BG, Yang WS, Hong J, Kang T, et al. Promiscuous methionyl-tRNA synthetase mediates adaptive mistranslation to protect cells against oxidative stress. J Cell Sci. 2014;127(Pt 19):4234–45. doi: 10.1242/jcs.152470 25097229.
63. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB, Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20(7):1126–67. doi: 10.1089/ars.2012.5149 23991888.
64. Dickinson BC, Chang CJ, Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat Chem Biol. 2011;7(8):504–11. doi: 10.1038/nchembio.607 21769097.
65. Tan HY, Wang N, Li S, Hong M, Wang X, Feng Y, The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases. Oxid Med Cell Longev. 2016;2016:2795090. doi: 10.1155/2016/2795090 27143992.
66. Das P, Lahiri A, Lahiri A, Chakravortty D, Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog. 2010;6(6):e1000899. doi: 10.1371/journal.ppat.1000899 20585552.
67. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009;5(4):e1000371. doi: 10.1371/journal.ppat.1000371 19360123.
68. Munder M, Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol. 2009;158(3):638–51. doi: 10.1111/j.1476-5381.2009.00291.x 19764983.
69. Burrack KS, Tan JJ, McCarthy MK, Her Z, Berger JN, Ng LF, et al. Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells. PLoS Pathog. 2015;11(10):e1005191. doi: 10.1371/journal.ppat.1005191 26436766.
70. Stoermer KA, Burrack A, Oko L, Montgomery SA, Borst LB, Gill RG, et al. Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus. J Immunol. 2012;189(8):4047–59. doi: 10.4049/jimmunol.1201240 22972923.
71. Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, et al. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 2011;7(10):e1002322. doi: 10.1371/journal.ppat.1002322 22028657.
72. Perdiguero B, Esteban M, The interferon system and vaccinia virus evasion mechanisms. J Interferon Cytokine Res. 2009;29(9):581–98. doi: 10.1089/jir.2009.0073 19708815.
73. Stuart JH, Sumner RP, Lu Y, Snowden JS, Smith GL, Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2. PLoS Pathog. 2016;12(12):e1005955. doi: 10.1371/journal.ppat.1005955 27907166.
74. Guerra S, Lopez-Fernandez LA, Pascual-Montano A, Munoz M, Harshman K, Esteban M, Cellular gene expression survey of vaccinia virus infection of human HeLa cells. Journal of virology. 2003;77(11):6493–506. Epub 2003/05/14. doi: 10.1128/JVI.77.11.6493-6506.2003 12743306.
75. Arakawa Y, Cordeiro JV, Schleich S, Newsome TP, Way M, The release of vaccinia virus from infected cells requires RhoA-mDia modulation of cortical actin. Cell host & microbe. 2007;1(3):227–40. Epub 2007/11/17. doi: 10.1016/j.chom.2007.04.006 18005701.
76. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP, ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol. 2005;25(15):6338–45. doi: 10.1128/MCB.25.15.6338-6345.2005 16024773.
77. Vives-Bauza C, Yang L, Manfredi G, Assay of mitochondrial ATP synthesis in animal cells and tissues. Methods Cell Biol. 2007;80:155–71. doi: 10.1016/S0091-679X(06)80007-5 17445693.
78. Wittig I, Braun HP, Schagger H, Blue native PAGE. Nat Protoc. 2006;1(1):418–28. doi: 10.1038/nprot.2006.62 17406264.
79. Malik AN, Czajka A, Cunningham P, Accurate quantification of mouse mitochondrial DNA without co-amplification of nuclear mitochondrial insertion sequences. Mitochondrion. 2016;29:59–64. doi: 10.1016/j.mito.2016.05.003 27181048.
80. Martinez-Bartolome S, Navarro P, Martin-Maroto F, Lopez-Ferrer D, Ramos-Fernandez A, Villar M, et al. Properties of average score distributions of SEQUEST: the probability ratio method. Mol Cell Proteomics. 2008;7(6):1135–45. Epub 2008/02/28. doi: 10.1074/mcp.M700239-MCP200 18303013.
81. Navarro P, Vazquez J, A refined method to calculate false discovery rates for peptide identification using decoy databases. J Proteome Res. 2009;8(4):1792–6. Epub 2009/08/29. doi: 10.1021/pr800362h 19714873.
82. Bonzon-Kulichenko E, Garcia-Marques F, Trevisan-Herraz M, Vazquez J, Revisiting peptide identification by high-accuracy mass spectrometry: problems associated with the use of narrow mass precursor windows. J Proteome Res. 2015;14(2):700–10. Epub 2014/12/17. doi: 10.1021/pr5007284 25494653.
83. Navarro P, Trevisan-Herraz M, Bonzon-Kulichenko E, Nunez E, Martinez-Acedo P, Perez-Hernandez D, et al. General statistical framework for quantitative proteomics by stable isotope labeling. Journal of proteome research. 2014;13(3):1234–47. Epub 2014/02/12. doi: 10.1021/pr4006958 24512137.
84. Garcia-Marques F, Trevisan-Herraz M, Martinez-Martinez S, Camafeita E, Jorge I, Lopez JA, et al. A Novel Systems-Biology Algorithm for the Analysis of Coordinated Protein Responses Using Quantitative Proteomics. Mol Cell Proteomics. 2016;15(5):1740–60. doi: 10.1074/mcp.M115.055905 26893027.
85. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437(7061):1032–7. Epub 2005/09/02. doi: 10.1038/nature03985 16136080.
86. Ficenec D, Osborne M, Pradines J, Richards D, Felciano R, Cho RJ, et al. Computational knowledge integration in biopharmaceutical research. Brief Bioinform. 2003;4(3):260–78. Epub 2003/10/30. 14582520.
87. Huang da W, Sherman BT, Zheng X, Yang J, Imamichi T, Stephens R, et al. Extracting biological meaning from large gene lists with DAVID. Curr Protoc Bioinformatics. 2009;Chapter 13:Unit 13 1. Epub 2009/09/04. doi: 10.1002/0471250953.bi1311s27 19728287.
88. Thomas S, Bonchev D, A survey of current software for network analysis in molecular biology. Hum Genomics. 2010;4(5):353–60. doi: 10.1186/1479-7364-4-5-353 20650822.
89. Codrea MC, Nahnsen S, Platforms and Pipelines for Proteomics Data Analysis and Management. Adv Exp Med Biol. 2016;919:203–15. doi: 10.1007/978-3-319-41448-5_9 27975218.